Header Logo

Connection

HELEN PIWNICA-WORMS to Poly(ADP-ribose) Polymerase Inhibitors

Back to Details
This is a "connection" page, showing publications HELEN PIWNICA-WORMS has written about Poly(ADP-ribose) Polymerase Inhibitors.
HELEN PIWNICA-WORMS
Connection Strength
0.227
Poly(ADP-ribose) Polymerase Inhibitors
  1. BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in BRCA1-Deficient Cancers. Cancer Discov. 2024 Aug 02; 14(8):1476-1495.
    View in: PubMed
    Score: 0.170
  2. Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant. J Clin Oncol. 2020 02 10; 38(5):388-394.
    View in: PubMed
    Score: 0.030
  3. CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib. Cancer Res. 2017 07 15; 77(14):3870-3884.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.